Novartis India Share Price in 2005: Chart, Monthly Trends, & Analysis

How did Novartis India shares perform in 2005?

Let's find out!

Novartis India share price in 2005 was ₹589.65 Its price on 1st January 2005 was ₹694.4, and by 31st December 2005 it moved to ₹589.65, giving a negative return of -15.09% for the year.

Novartis India Share Open, High, Low, and Close prices for the Year 2005 are as follows:

Open	High	Low	Close
₹694.4	₹694.4	₹441	₹589.65
1st Jan 2005	Occured in Jan 2005	Occured in Dec 2005	31st Dec 2005

This page will help you understand how Novartis India performed in 2005. Let's get started.

For complete insights into Novartis India’s incredible stock price performance and growth, see: Novartis India Historical Share Price Data from its IPO to 2025

Table: Novartis India Share Monthly Close, Low, High Prices for 2005

Month	Novartis India	Change%	↑High - ↓Low
Jan	₹600.1	-	↑ ₹694.4 ↓ ₹553.4
Feb	₹539.2	-10.2%	↑ ₹660 ↓ ₹531
Mar	₹496.35	-8%	↑ ₹595 ↓ ₹450
Apr	₹456.5	-8.1%	↑ ₹538.75 ↓ ₹450.05
May	₹494.85	8.4%	↑ ₹515 ↓ ₹452
Jun	₹500.7	1.1%	↑ ₹525 ↓ ₹483
Jul	₹580.95	16%	↑ ₹611 ↓ ₹500
Aug	₹551.95	-5%	↑ ₹635 ↓ ₹525
Sep	₹521.45	-5.6%	↑ ₹590 ↓ ₹501
Oct	₹464.65	-10.9%	↑ ₹586 ↓ ₹452
Nov	₹525.2	13%	↑ ₹537.5 ↓ ₹461.25
Dec	₹589.65	12.2%	↑ ₹597.5 ↓ ₹441

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Novartis India in 2005?

In 2005, the opening price of Novartis India share was ₹694.40. Today, the price stands at ₹672.25, reflecting a growth of -3.19%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2005 would have become ₹9,681.01 by 2025. This represents a CAGR of -0.16%.

---

You might also like to check: Novartis India Stock Price in 2004 or Novartis India Stock Price in 2006

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.